Hemant Shintre
Research Subjects
Hemant Shintre has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Payyappilly G. Paul
Paul's Hospital, Centre for Advanced Endoscopy & Infertility, Kochi, Kerala, India
8 shared publications Sumina Mannur
Centre for Advanced Endoscopy & Infertility, Paul's Hospital, Kochi, Kerala, India
5 shared publicationsGeorge Paul
Centre for Advanced Endoscopy & Infertility, Paul's Hospital, Kochi, Kerala, India
4 shared publicationsGunjan Gulati
Centre for Advanced Endoscopy & Infertility, Paul's Hospital, Kochi, Kerala, India
4 shared publicationsBindu Rani
Department of Obstetrics and Gynaecology, Lilavati Hospital and Research Centre, Bandra (W), Mumbai, Maharashtra, India
3 shared publications- George Paul
Paul's Hospital, Centre for Advanced Endoscopy & Infertility, Kochi, Kerala, India
3 shared publications
Latest Publications
- 1 October 2018
- Published by SAGE Publications in Journal of Gynecologic Surgery
- Vol. 34 (5) , 248-251
A Unique Case of Rectosigmoid Mesh Erosion Presenting as Left Thigh Sinus Tract Abscess Following Laparoscopic Sacrocervicopexy
Background: Mesh erosion is a well-known complication after use of mesh for pelvic organ prolapse repair. The most common site of mesh erosion is the vagina. Nonvaginal mesh erosions into bowel and bladder are rare. Mesh erosion into the bowel can be a devastating complication with significant morbidity and could need multiple surgeries for repair and recovery. Mesh erosion presenting as thigh sinus-tract abscess is unusual and rare. Case: A 41-year-old female had rectosigmoid mesh erosion after laparoscopic sacrocervicopexy; this condition presented with a recurrent left sinus-tract thigh abscess. Rectosigmoid mesh erosion, with a thigh sinus-tract abscess was suspected on the basis of local and pelvic examination findings as well as ultrasonography findings. This case was managed by excision of the mesh with closure of the sinus tract, and bowel diversion and repair. Results: This patient was asymptomatic after 3 years of follow-up. Conclusions: Total excision of the mesh with repair of the bowel defect seems to be an appropriate treatment for patients with mesh eroding into the bowel. Sometimes bowel diversion (ileostomy or colostomy) is needed. Any unusual anorectal or gynecologic symptom should alarm the physician, and the possibility of mesh erosion should be suspected. (J GYNECOL SURG 20XX:000)
- 1 October 2018
- Published by SAGE Publications in Journal of Gynecologic Surgery
- Vol. 34 (5) , 248-251
A Unique Case of Rectosigmoid Mesh Erosion Presenting as Left Thigh Sinus Tract Abscess Following Laparoscopic Sacrocervicopexy
Background: Mesh erosion is a well-known complication after use of mesh for pelvic organ prolapse repair. The most common site of mesh erosion is the vagina. Nonvaginal mesh erosions into bowel and bladder are rare. Mesh erosion into the bowel can be a devastating complication with significant morbidity and could need multiple surgeries for repair and recovery. Mesh erosion presenting as thigh sinus-tract abscess is unusual and rare. Case: A 41-year-old female had rectosigmoid mesh erosion after laparoscopic sacrocervicopexy; this condition presented with a recurrent left sinus-tract thigh abscess. Rectosigmoid mesh erosion, with a thigh sinus-tract abscess was suspected on the basis of local and pelvic examination findings as well as ultrasonography findings. This case was managed by excision of the mesh with closure of the sinus tract, and bowel diversion and repair. Results: This patient was asymptomatic after 3 years of follow-up. Conclusions: Total excision of the mesh with repair of the bowel defect seems to be an appropriate treatment for patients with mesh eroding into the bowel. Sometimes bowel diversion (ileostomy or colostomy) is needed. Any unusual anorectal or gynecologic symptom should alarm the physician, and the possibility of mesh erosion should be suspected. (J GYNECOL SURG 20XX:000)
- 1 September 2018
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 228, 130-136
Extrauterine adenomyoma: a review of the literature
- 1 September 2018
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 228, 130-136
Extrauterine adenomyoma: a review of the literature
- 1 September 2018
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 25 (6) , 946-947
Round Ligament Adenomyoma
- 1 September 2018
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 25 (6) , 946-947
Round Ligament Adenomyoma
- 16 May 2018
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 68 (4) , 314-319
Thirteen Years of Experience with Opportunistic Bilateral Salpingectomy During TLH in Low-Risk Premenopausal Women
Opportunistic bilateral salpingectomy (OBS), also called as prophylactic salpingectomy or risk-reducing salpingectomy is the concurrent removal of the fallopian tubes in premenopausal women. Though there are some studies comparing the intraoperative complications and effect of salpingectomy on ovarian reserve, limited data are available on long-term follow-up after OBS.
- 16 May 2018
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 68 (4) , 314-319
Thirteen Years of Experience with Opportunistic Bilateral Salpingectomy During TLH in Low-Risk Premenopausal Women
Opportunistic bilateral salpingectomy (OBS), also called as prophylactic salpingectomy or risk-reducing salpingectomy is the concurrent removal of the fallopian tubes in premenopausal women. Though there are some studies comparing the intraoperative complications and effect of salpingectomy on ovarian reserve, limited data are available on long-term follow-up after OBS.
- 1 April 2018
- Published by SAGE Publications in Journal of Gynecologic Surgery
- Vol. 34 (2) , 53-57
Myomectomy Scar Pregnancy: A Rare Complication of Myomectomy
Background: Myomectomy scar pregnancy is a rare form of intramural pregnancy in which the gestational sac is implanted within the myometrium, separate from the endometrial cavity and fallopian tubes and in the previous myomectomy scar. This review was written to increase awareness about the rare complication of intramural scar pregnancy after myomectomy. Illustrated by a case report of a myomectomy scar pregnancy following laparoscopic myomectomy, the review covers 3 cases reported in the literature. Illustrative Case: A 31-year-old female, gravida 3, with a history of myomectomy presented to the Centre for Advanced Endoscopy and Infertility of Paul's Hospital in Kochi, Kerala, India, at 9 weeks of gestation for confirmation of fetal viability. A transvaginal ultrasound scan indicated that there was a potential left interstitial pregnancy. However, laparoscopy revealed that this patient actually had an intramural pregnancy in her previous myomectomy scar. This patient's condition was managed successfully via laparoscopy. Results: An electronic database search yielded 68 cases of intramural scar pregnancy. However, only 3 cases of intramural scar pregnancies after myomectomy were identified. Conclusion: An unusual location of an early pregnancy on TVS should raise the suspicion of myomectomy scar ectopic pregnancy in a woman with a previous myomectomy. (J GYNECOL SURG 20XX:00)
- 1 April 2018
- Published by SAGE Publications in Journal of Gynecologic Surgery
- Vol. 34 (2) , 53-57
Myomectomy Scar Pregnancy: A Rare Complication of Myomectomy
Background: Myomectomy scar pregnancy is a rare form of intramural pregnancy in which the gestational sac is implanted within the myometrium, separate from the endometrial cavity and fallopian tubes and in the previous myomectomy scar. This review was written to increase awareness about the rare complication of intramural scar pregnancy after myomectomy. Illustrated by a case report of a myomectomy scar pregnancy following laparoscopic myomectomy, the review covers 3 cases reported in the literature. Illustrative Case: A 31-year-old female, gravida 3, with a history of myomectomy presented to the Centre for Advanced Endoscopy and Infertility of Paul's Hospital in Kochi, Kerala, India, at 9 weeks of gestation for confirmation of fetal viability. A transvaginal ultrasound scan indicated that there was a potential left interstitial pregnancy. However, laparoscopy revealed that this patient actually had an intramural pregnancy in her previous myomectomy scar. This patient's condition was managed successfully via laparoscopy. Results: An electronic database search yielded 68 cases of intramural scar pregnancy. However, only 3 cases of intramural scar pregnancies after myomectomy were identified. Conclusion: An unusual location of an early pregnancy on TVS should raise the suspicion of myomectomy scar ectopic pregnancy in a woman with a previous myomectomy. (J GYNECOL SURG 20XX:00)
- Open Access
- 1 January 2018
- Published by Medknow in Gynecology and Minimally Invasive Therapy
- Vol. 7 (3) , 124-126
Parasitic myomas: An unusual risk after morcellation
A 24-year-old unmarried woman had undergone laparoscopic myomectomy for single degenerated myoma of size 15 cm. Uncontained morcellation of the myoma was done with an electromechanical morcellator. Two years later, she presented with abdominal pain, and laparoscopy revealed enlarged uterus (20 weeks) with multiple degenerated myomas. There were multiple parasitic myomas measuring 1–3 cm in the pelvis and anterior abdominal wall which were removed laparoscopically. Histopathology of all the myomas including parasitic myomas confirmed the diagnosis of leiomyoma. The formation of parasitic myomas was assumed to be due to the myomatous fragments which were left behind during morcellation at the time of initial myomectomy. Methods to prevent this complication are colpotomy, mini-laparotomy, or in-bag morcellation.
- 1 January 2018
- Published by Medknow in Gynecology and Minimally Invasive Therapy
- Vol. 7 (3) , 124-126
Open AccessParasitic myomas: An unusual risk after morcellation
A 24-year-old unmarried woman had undergone laparoscopic myomectomy for single degenerated myoma of size 15 cm. Uncontained morcellation of the myoma was done with an electromechanical morcellator. Two years later, she presented with abdominal pain, and laparoscopy revealed enlarged uterus (20 weeks) with multiple degenerated myomas. There were multiple parasitic myomas measuring 1–3 cm in the pelvis and anterior abdominal wall which were removed laparoscopically. Histopathology of all the myomas including parasitic myomas confirmed the diagnosis of leiomyoma. The formation of parasitic myomas was assumed to be due to the myomatous fragments which were left behind during morcellation at the time of initial myomectomy. Methods to prevent this complication are colpotomy, mini-laparotomy, or in-bag morcellation.
- 1 November 2017
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 24 (7) , 1096-1103
Postoperative Pulmonary Complications Following Laparoscopy
- 1 November 2017
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 24 (7) , 1096-1103
Postoperative Pulmonary Complications Following Laparoscopy
- 1 September 2017
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 24 (6) , 893-894
Laparoscopic Myomectomy for a Plethora of Submucous Myomas
- 1 September 2017
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 24 (6) , 893-894
Laparoscopic Myomectomy for a Plethora of Submucous Myomas
- 1 August 2017
- Published by Jaypee Brothers Medical Publishing in International Journal of Infertility & Fetal Medicine
- Vol. 8 (2) , 68-74
Comparison between Day 2 and Day 3 Embryo Transfer following in vitro Fertilization/Intracytoplasmic Sperm Injection
Aim: To compare reproductive outcomes of day 2 and day 3 embryo transfer (ET).Materials and methods: In this retrospective records study, all couples who underwentin vitrofertilization/intracytoplasmic sperm injection (IVF/ICSI) and ET cycles at Lilavati Hospital & Research Centre over a period of 1 year were studied. Data were collected and analyzed by chi-square test and unpairedt-test by Statistical Package for the Social Sciences, version 16.Results: There was no statistically significant difference between the clinical and demographic parameters of group day 3 and day 2 ET. In our study, clinical pregnancy rate was 45% in day 3 ET and 36.5% in day 2 ET group [odds ratio (OR) 1.43, p-value 0.49]. The ongoing pregnancy rate was 39.2% in day 3 ET and 26.9% in day 2 ET group (OR 1.75, p-value 0.26). We observed that the miscarriage rate was 5.9% in day 3 ET and was 5.8% in day 2 ET group (p-value 0.69, OR 1.02). We observed one case each of multiple pregnancy, ectopic pregnancy, and fetal anomaly (anencephaly) in day 2 ET group, while in day 3 ET group, no such case was detected.Conclusion: There are chances that day 3 ET has better clinical and ongoing pregnancy rates than day 2 ET, but the difference is not statistically significant. Study showed similar miscarriage rates in both groups and very low incidence of complications like multiple pregnancy, ectopic pregnancy, and fetal anomaly. So, it is safe to schedule and transfer embryos either on day 2 or on day 3 for planning and programming cycles in coordination with patient and IVF team and for adjusting weekends (nonworking days).Clinical significance: Many steps of IVF procedure became standardized. However, the optimum timing of ET is still debatable. Several studies comparing ET on day 2vsday 3 after oocyte retrieval have been performed, but the conclusions are conflicting. Despite development in culture media allowing blastocyst transfer, many centers still practice day 2/3 ET.How to cite this article: Shintre HS, Pai HD, Talreja D, Shah KR. Comparison between Day 2 and Day 3 Embryo Transfer followingin vitroFertilization/Intracytoplasmic Sperm Injection. Int J Infertil Fetal Med 2017;8(2):68-74.
- 1 August 2017
- Published by Jaypee Brothers Medical Publishing in International Journal of Infertility & Fetal Medicine
- Vol. 8 (2) , 68-74
Comparison between Day 2 and Day 3 Embryo Transfer following in vitro Fertilization/Intracytoplasmic Sperm Injection
Aim: To compare reproductive outcomes of day 2 and day 3 embryo transfer (ET).Materials and methods: In this retrospective records study, all couples who underwentin vitrofertilization/intracytoplasmic sperm injection (IVF/ICSI) and ET cycles at Lilavati Hospital & Research Centre over a period of 1 year were studied. Data were collected and analyzed by chi-square test and unpairedt-test by Statistical Package for the Social Sciences, version 16.Results: There was no statistically significant difference between the clinical and demographic parameters of group day 3 and day 2 ET. In our study, clinical pregnancy rate was 45% in day 3 ET and 36.5% in day 2 ET group [odds ratio (OR) 1.43, p-value 0.49]. The ongoing pregnancy rate was 39.2% in day 3 ET and 26.9% in day 2 ET group (OR 1.75, p-value 0.26). We observed that the miscarriage rate was 5.9% in day 3 ET and was 5.8% in day 2 ET group (p-value 0.69, OR 1.02). We observed one case each of multiple pregnancy, ectopic pregnancy, and fetal anomaly (anencephaly) in day 2 ET group, while in day 3 ET group, no such case was detected.Conclusion: There are chances that day 3 ET has better clinical and ongoing pregnancy rates than day 2 ET, but the difference is not statistically significant. Study showed similar miscarriage rates in both groups and very low incidence of complications like multiple pregnancy, ectopic pregnancy, and fetal anomaly. So, it is safe to schedule and transfer embryos either on day 2 or on day 3 for planning and programming cycles in coordination with patient and IVF team and for adjusting weekends (nonworking days).Clinical significance: Many steps of IVF procedure became standardized. However, the optimum timing of ET is still debatable. Several studies comparing ET on day 2vsday 3 after oocyte retrieval have been performed, but the conclusions are conflicting. Despite development in culture media allowing blastocyst transfer, many centers still practice day 2/3 ET.How to cite this article: Shintre HS, Pai HD, Talreja D, Shah KR. Comparison between Day 2 and Day 3 Embryo Transfer followingin vitroFertilization/Intracytoplasmic Sperm Injection. Int J Infertil Fetal Med 2017;8(2):68-74.
- Open Access
- 31 January 2017
- Published by Medip Academy in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
- Vol. 6 (2) , 761-765
Use of intrauterine balloon tamponade in successful conservative management of life threatening menorrhagia in a patient with idiopathic thrombocytopenic purpura and severe anemia
A 45-year-old woman was brought into the emergency ward of a tertiary care hospital. The patient gave a history of excess bleeding and passage of clots per vaginum since the past 15 days. The patient had a history of severe headaches, body ache, giddiness and vomiting. She was diagnosed with idiopathic thrombocytopenic purpura (ITP) and severe anemia six months before this incidence. The authors performed a diagnostic pelvic and transvaginal ultrasound and reported the presence of uterine fibroids. They determined that these fibroids had aggravated the bleeding which was caused by ITP. The diagnosis of ITP coupled with severe anemia prevented the authors from using the traditional approach of a hysterectomy in such a case. She was administered tranexamic acid, testosterone enanthate, blood, intravenous immunoglobulins, steroids and platelets transfusion. Uterine artery embolization (UAE) was tried for arresting menorrhagia, but was unsuccessful. Finally, a Bakri® balloon, normally used for management of post-partum hemorrhage (PPH), was inserted and retained for 48 hrs.. The bleeding gradually ceased and significant improvements in hematocrit and platelet count were observed. However, the patient then suffered from a deep vein thrombosis (DVT) in the lower extremity, which was treated with low molecular weight heparin (LMWH), a thrombectomy and an Inferior vena cava Filter. Patient was advised a hysterectomy to curb her symptoms, however, she was too exhausted of surgical procedures and refused. Therefore, the authors decided to employ the use of Selective Estrogen Receptor Molecule Therapy (SERM). 3-months post-intervention, patient is thriving and stable.
- 31 January 2017
- Published by Medip Academy in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
- Vol. 6 (2) , 761-765
Open AccessUse of intrauterine balloon tamponade in successful conservative management of life threatening menorrhagia in a patient with idiopathic thrombocytopenic purpura and severe anemia
A 45-year-old woman was brought into the emergency ward of a tertiary care hospital. The patient gave a history of excess bleeding and passage of clots per vaginum since the past 15 days. The patient had a history of severe headaches, body ache, giddiness and vomiting. She was diagnosed with idiopathic thrombocytopenic purpura (ITP) and severe anemia six months before this incidence. The authors performed a diagnostic pelvic and transvaginal ultrasound and reported the presence of uterine fibroids. They determined that these fibroids had aggravated the bleeding which was caused by ITP. The diagnosis of ITP coupled with severe anemia prevented the authors from using the traditional approach of a hysterectomy in such a case. She was administered tranexamic acid, testosterone enanthate, blood, intravenous immunoglobulins, steroids and platelets transfusion. Uterine artery embolization (UAE) was tried for arresting menorrhagia, but was unsuccessful. Finally, a Bakri® balloon, normally used for management of post-partum hemorrhage (PPH), was inserted and retained for 48 hrs.. The bleeding gradually ceased and significant improvements in hematocrit and platelet count were observed. However, the patient then suffered from a deep vein thrombosis (DVT) in the lower extremity, which was treated with low molecular weight heparin (LMWH), a thrombectomy and an Inferior vena cava Filter. Patient was advised a hysterectomy to curb her symptoms, however, she was too exhausted of surgical procedures and refused. Therefore, the authors decided to employ the use of Selective Estrogen Receptor Molecule Therapy (SERM). 3-months post-intervention, patient is thriving and stable.